Only 106 spots left

~106 spots leftby Mar 2026

Intensive CBT for PTSD

Recruiting in Palo Alto (17 mi)

Overseen byEllen Teng, PhD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: Baylor College of Medicine

Must be taking: Psychotropic

Disqualifiers: Mania, Psychosis, Suicidal ideation, others

No Placebo Group

Trial Summary

What is the purpose of this trial?

The goal of this clinical trial is to compare two different intensive formats of delivering cognitive-behavioral treatment for people with PTSD and anxiety disorders. The main questions it aims to answer are: * Is iTCBT delivered in individual and group formats more effective than TAU in improving anxiety symptoms and quality of life? * For treatment non-responders, is iTCBT-Enhanced more effective than TAU improving anxiety symptoms and quality of life? * Does iTCBT-Individual produce a larger improvement in anxiety and quality of life compared with iTCBT-Group? Participants will undergo several assessments throughout the course of the study. Based on randomization, they will receive: (1) iTCBT in an individual format over a 2-week period, (2) iTCBT in a group format over a 2-day period, or (3) usual care. Those who do not show a response to treatment will receive 4 additional individual therapy sessions.

Do I have to stop taking my current medications for the trial?

The trial does not specify if you need to stop taking your current medications, but you must be stable on psychotropic medication for 4 weeks before participating. This suggests you can continue your current medications if they have been stable for that period.

What data supports the effectiveness of the treatment Intensive CBT for PTSD?

Research shows that intensive cognitive therapy for PTSD is as effective as weekly treatment, and cognitive-behavioral therapy (CBT) significantly improves PTSD symptoms, especially in those with severe PTSD. Additionally, intensive outpatient programs for PTSD, which include trauma-focused therapies, have high completion rates and effectively reduce PTSD symptoms.¹ ² ³ ⁴ ⁵

Is intensive CBT for PTSD safe for humans?

Research suggests that intensive trauma-focused cognitive behavioral therapy (CBT) for PTSD is generally safe, with very low rates of adverse events and only a few cases of symptom worsening.² ⁶ ⁷ ⁸ ⁹

How is Intensive CBT for PTSD different from other treatments for PTSD?

Intensive CBT for PTSD, including iTCBT-G and iTCBT-I, is unique because it offers a concentrated and focused approach to therapy, often involving multiple sessions over a short period, which can lead to faster symptom reduction and improved treatment retention compared to traditional, less intensive therapies.² ⁴ ⁶ ⁷ ⁹

Research Team

Ellen Teng, PhD

Principal Investigator

Michael E. DeBakey VA Medical Center

Eligibility Criteria

This trial is for veterans and service members over 18 with an anxiety disorder like PTSD, panic disorder, or social anxiety. They should have moderate-to-poor life satisfaction and be stable on any psychotropic medication for at least 4 weeks. Participants must be open to random treatment assignment.

Inclusion Criteria

I am willing to be assigned to a treatment group by chance.

I have been diagnosed with an anxiety disorder.

I have been on stable mental health medication for at least 4 weeks.

See 2 more

Exclusion Criteria

I do not have severe depression or thoughts of harming myself that would stop me from receiving treatment.

Moderate-to-severe cognitive impairment as indicated by the SLUMS (a score below 20)

I am currently experiencing symptoms of mania or psychosis.

See 2 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive iTCBT in either individual or group formats. Individual format involves 12 hours over 2 weeks, while group format involves 12 hours over 2 days.

2 weeks

4 visits (in-person) for individual format, 2 visits (in-person) for group format

Enhanced Treatment

For treatment non-responders, 4 additional 90-minute individual therapy sessions are provided over 2 weeks.

2 weeks

4 visits (in-person)

Follow-up

Participants are monitored for changes in anxiety and quality of life at 3- and 6-month intervals.

6 months

Treatment Details

Interventions

iTCBT-G (Behavioral Intervention)
iTCBT-I (Behavioral Intervention)
TAU (Behavioral Intervention)
Transdiagnostic Cognitive Behavioral Therapy (Behavioral Intervention)

Trial OverviewThe study compares two intensive cognitive-behavioral therapies (iTCBT) in individual (over 2 weeks) and group formats (over 2 days), against usual care (TAU). It checks which method better improves symptoms of anxiety and quality of life. Non-responders get extra individual sessions.

Participant Groups

3Treatment groups

Experimental Treatment

Active Control

Group I: iTCBT-I (Intensive Transdiagnostic Cognitive Behavioral Therapy-Individual)Experimental Treatment1 Intervention

Patients in this arm will receive transdiagnostic CBT delivered in an intensive individual format over 2 weeks. Intensive Transdiagnostic Cognitive Behavior Therapy-Individual (iTCBT-I): Participants randomized to this condition will receive 12 hours of treatment in four 3 hour sessions, over a 2-week period. Treatment consists of psychoeducation, cognitive restructuring, and exposure exercises. For treatment non-responders (i.e., BAI score decrease \< 10), patients will receive 4 additional 90 minute sessions of individual therapy over a 2-week period (iTCBT-Enhanced). These sessions will identify areas where participants might benefit from more in-depth focus on specific concepts taught in the treatment.

Group II: iTCBT-G (Intensive Transdiagnostic Cognitive Behavioral Therapy-Group)Active Control1 Intervention

Patients in this arm will receive transdiagnostic CBT delivered in an intensive group format over 2 weeks. Intensive Transdiagnostic Cognitive Behavior Therapy-Group (iTCBT-G): Participants randomized to this condition will receive 12 hours of treatment over a 2-day period (6 hrs each day). Treatment consists of psychoeducation, cognitive restructuring, and exposure exercises. For treatment non-responders (i.e., BAI score decrease \< 10), patients will receive 4 additional 90 minute sessions of individual therapy over a 2-week period (iTCBT-Enhanced). These sessions will identify areas where participants might benefit from more in-depth focus on specific concepts taught in the treatment.

Group III: Treatment as Usual (TAU)Active Control1 Intervention

Patients in this arm will not receive transdiagnostic CBT but will receive treatment as usual, which may include other forms of psychotherapy and/or medication.

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:

Michael E. DeBakey VA Medical CenterHouston, TX

Loading ...

Who Is Running the Clinical Trial?

Baylor College of Medicine

Lead Sponsor

Trials

1044

Patients Recruited

6,031,000+

United States Department of Defense

Collaborator

Trials

940

Patients Recruited

339,000+

Findings from Research

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Intensive cognitive therapy for post-traumatic stress disorder in routine clinical practice: A matched comparison audit.Murray, H., El-Leithy, S., Billings, J.[2018]

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Clients' Experiences of Returning to the Trauma Site during PTSD Treatment: An Exploratory Study.Murray, H., Merritt, C., Grey, N.[2018]

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

A randomized controlled trial of cognitive-behavioral treatment for posttraumatic stress disorder in severe mental illness.Mueser, KT., Rosenberg, SD., Xie, H., et al.[2022]

Trauma-Focused Cognitive-Behavioral Therapy (TF-CBT) is a highly effective treatment for reducing posttraumatic stress symptoms in children, supported by high-level evidence from ten randomized controlled trials (RCTs).

While TF-CBT shows promise in addressing trauma-related symptoms, its effectiveness in reducing behavioral problems and depression symptoms remains less certain, highlighting the need for further research to optimize its application across diverse populations.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Trauma-focused cognitive-behavioral therapy for children and adolescents: assessing the evidence.de Arellano, MA., Lyman, DR., Jobe-Shields, L., et al.[2022]

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Feasibility of an intensive outpatient treatment program for posttraumatic stress disorder within the veterans health care administration.Yamokoski, C., Flores, H., Facemire, V., et al.[2023]

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Asylum-seekers' experiences of trauma-focused cognitive behaviour therapy for post-traumatic stress disorder: a qualitative study.Vincent, F., Jenkins, H., Larkin, M., et al.[2018]

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Intensive prolonged exposure therapy for chronic PTSD patients following multiple trauma and multiple treatment attempts.Hendriks, L., de Kleine, RA., Broekman, TG., et al.[2020]

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

An intensive form of trauma focused cognitive behaviour therapy in an acute adolescent inpatient unit: An uncontrolled open trial.Cabrera, N., Moffitt, G., Jairam, R., et al.[2022]

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Acceptability of a Plasticity-Focused Serious Game Intervention for Posttraumatic Stress Disorder: User Requirements Analysis.Jones, M., Denisova, A., Mitchell, S., et al.[2020]